Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
Koen B Pouwels,Thomas House,Emma Pritchard,Julie V Robotham,Paul J Birrell,Andrew Gelman,Karina-Doris Vihta,Nikola Bowers,Ian Boreham,Heledd Thomas,James Lewis,Iain Bell,John I Bell,John N Newton,Jeremy Farrar,Ian Diamond,Pete Benton,Ann Sarah Walker,COVID-19 Infection Survey Team,A Sarah Walker,Derrick Crook,Philippa C Matthews,Tim Peto,Nicole Stoesser,Alison Howarth,George Doherty,James Kavanagh,Kevin K Chau,Stephanie B Hatch,Daniel Ebner,Lucas Martins Ferreira,Thomas Christott,Brian D Marsden,Wanwisa Dejnirattisai,Juthathip Mongkolsapaya,Sarah Hoosdally,Richard Cornall,David I Stuart,Gavin Screaton,David Eyre,John Bell,Stuart Cox,Kevin Paddon,Tim James,Paul Birrell,Helena Jordan,Tim Sheppard,Graham Athey,Dan Moody,Leigh Curry,Pamela Brereton,Jodie Hay,Harper Vansteenhouse,Alex Lambert,Emma Rourke,Stacey Hawkes,Sarah Henry,James Scruton,Peter Stokes,Tina Thomas,John Allen,Russell Black,Heather Bovill,David Braunholtz,Dominic Brown,Sarah Collyer,Megan Crees,Colin Daglish,Byron Davies,Hannah Donnarumma,Julia Douglas-Mann,Antonio Felton,Hannah Finselbach,Eleanor Fordham,Alberta Ipser,Joe Jenkins,Joel Jones,Katherine Kent,Geeta Kerai,Lina Lloyd,Victoria Masding,Ellie Osborn,Alpi Patel,Elizabeth Pereira,Tristan Pett,Melissa Randall,Donna Reeve,Palvi Shah,Ruth Snook,Ruth Studley,Esther Sutherland,Eliza Swinn,Anna Tudor,Joshua Weston,Shayla Leib,James Tierney,Gabor Farkas,Raf Cobb,Folkert Van Galen,Lewis Compton,James Irving,John Clarke,Rachel Mullis,Lorraine Ireland,Diana Airimitoaie,Charlotte Nash,Danielle Cox,Sarah Fisher,Zoe Moore,James McLean,Matt Kerby
DOI: https://doi.org/10.1016/S2468-2667(20)30282-6
Abstract:Background: Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Existing surveillance systems are generally not based on population samples and are not longitudinal in design. Methods: Samples were collected from individuals aged 2 years and older living in private households in England that were randomly selected from address lists and previous Office for National Statistics surveys in repeated cross-sectional household surveys with additional serial sampling and longitudinal follow-up. Participants completed a questionnaire and did nose and throat self-swabs. The percentage of individuals testing positive for SARS-CoV-2 RNA was estimated over time by use of dynamic multilevel regression and poststratification, to account for potential residual non-representativeness. Potential changes in risk factors for testing positive over time were also assessed. The study is registered with the ISRCTN Registry, ISRCTN21086382. Findings: Between April 26 and Nov 1, 2020, results were available from 1 191 170 samples from 280 327 individuals; 5231 samples were positive overall, from 3923 individuals. The percentage of people testing positive for SARS-CoV-2 changed substantially over time, with an initial decrease between April 26 and June 28, 2020, from 0·40% (95% credible interval 0·29-0·54) to 0·06% (0·04-0·07), followed by low levels during July and August, 2020, before substantial increases at the end of August, 2020, with percentages testing positive above 1% from the end of October, 2020. Having a patient-facing role and working outside your home were important risk factors for testing positive for SARS-CoV-2 at the end of the first wave (April 26 to June 28, 2020), but not in the second wave (from the end of August to Nov 1, 2020). Age (young adults, particularly those aged 17-24 years) was an important initial driver of increased positivity rates in the second wave. For example, the estimated percentage of individuals testing positive was more than six times higher in those aged 17-24 years than in those aged 70 years or older at the end of September, 2020. A substantial proportion of infections were in individuals not reporting symptoms around their positive test (45-68%, dependent on calendar time. Interpretation: Important risk factors for testing positive for SARS-CoV-2 varied substantially between the part of the first wave that was captured by the study (April to June, 2020) and the first part of the second wave of increased positivity rates (end of August to Nov 1, 2020), and a substantial proportion of infections were in individuals not reporting symptoms, indicating that continued monitoring for SARS-CoV-2 in the community will be important for managing the COVID-19 pandemic moving forwards. Funding: Department of Health and Social Care.